-
Small Cell SMASHERS Fireside Chat with Dr. Misty Shields
In October, we hosted a special Small Cell SMASHERS Fireside Chat with our two hosts, Misty Shields, MD, PhD, Indiana University School of Medicine, and Ann Steagall, LUNGevity’s... -
Podcast: Managing the Side Effects of Small Cell Lung Cancer Treatment
What side effects should you expect from small cell lung cancer treatment—and when should you call your care team? In this episode, small cell lung cancer (SCLC) survivor Vickie... -
Michelle Hills on End-of-Life Planning and Hospice Care
A message from Michelle: It’s important to know that we control the narrative. If done correctly, end-of-life and hospice care are the beginning of a new chapter of patient... -
Small Cell SMASHERS Fireside Chat with Dr. Benjamin Morris
In September, we were joined by Benjamin Morris, MD, CPRIT TRIUMPH postdoctoral fellow at UT MD Anderson Cancer Center. Dr. Morris discussed his research, the IASCLC Young... -
Podcast: What Do I Need to Know About Nutrition During Cancer Treatment?
Should you avoid sugar when you are living with lung cancer? Or should you eat anything you want? Are supplements something you need to consider? In this episode, non-small cell... -
Small Cell SMASHERS Fireside Chat with Dr. Jacob Sands
In August, we were joined by Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology and Assistant Professor of Medicine at Harvard Medical School. Dr. Sands... -
Podcast: Managing the Emotional Rollercoaster of Lung Cancer
Living with lung cancer can take more than just a physical toll—it comes with a myriad of feelings, like anxiety, fear, and grief. In this episode, non-small cell lung cancer... -
Real Progress and Real Gaps: Highlights of the 2026 AACR Disparities Report
I have spent my career focused on the intersection between cancer research and public health. Since joining LUNGevity over a decade ago, it has been nothing short of a privilege to... -
New Treatment Approved for ROS1-positive NSCLC
On July 22, 2026, the US Food and Drug Administration (FDA) announced the approval of zidesamtinib (Jideytro™) to treat patients with locally-advanced or metastatic ROS1-positive... -
Getting to the Bone of the Matter: Bone-Modifying Agents
LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient... -
Camila Bermúdez García: Turning Experience into Advocacy
Before lung cancer entered her life, 24-year-old Camila Bermudez Garcia was focused on building her future. Growing up as the oldest of three in Ponce, Puerto Rico, she was... -
Podcast: Clinical Trials - Who's Eligible, and How to Find One
How do clinical trials work? What actually happens when you enroll in one? And how do you find a trial that's right for you? In this episode, small cell lung cancer survivor Wendy...
Patient Gateway